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l. Introduction 
Recent a t tempts  by Jaf fe et  al. [ |  I to produce 
antibodies towards PGA I have resulted in an antise- 
,-ur.:t wh/ch cross-rcacled significantly with PGE ! and 
PGE 2. Levine and co-workers [2] have a t tempted  to 
obtain ant ibodies to PGE t in; rabbits by immuniz ing 
with PGE t -bov ine  serum albumin conjugates, but  
0brained ant ibodies directed main ly  against PGB 1 . 
Smlitar a t tempts  by Yu and Burke [3} have resulted 
in the product ion o f  PGE t antisera which cross 
:eacted to an equal extent  or more with the A and B 
pr0staglandins, and o f  PGA 1 antis~ra which cross 
reacted to a higher extent  w,~tix PGB t. Zusman et al. 
[4] have a t tempted  toproduce  ant ibodies to FGE 2 
but obtained antisera directed mainly against PGA 2 
and with cross reactivities towards P(;A 1 (53%) and 
PGE 2 (26~).  As a result o f  the~ studies [ 1 -4~,  sev- 
eral irxvestigatots [2, 3] have suggested that it would 
be very diff icult,  i f  not  impossible,  to obtain an*A- 
bodies directed specifically against he PGE and FGA 
pr0staglandins. 
The first report  on the successful product ion of  
ami-PGA 1 serum which is highly specific for ..i~A l
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Abbrc~,farions: 
PGE 1 • prosta~landin E ! ; PG E 2 , prostaglandin F 2; PGA I 
prostaglandin A l ; PGB!, prostaglandin Bt ; PGF tc~; pros- 
tagtandin Vt~; PGFs~,, pmstaglandin Vs0t. 
was reported by Styles and Rivetz [5] .  These authors 
immunized rabbits with poly L: lysine--PGA 1 conju- 
gate absorbed on Pneumococcus R 36A strains cells, 
and obtained PGA 1 antiserum which cross reacted 
somewhat with PGA 2 (9.7%), but only very minimal-  
iy with PGE t (2.9%). Yhis re por~ describes the rela- 
tive specificity o f  this PGAI  ant iserum towards PGA t 
and PGB I . Also included is a disct:ssion o f  the pro= 
rein carrier and method o f  immunizat ion as they af- 
feet the st~ccificity o f  an tisera raised against PGA I 
and against PGE i . 
2. Materials and methods 
Prestaglandin E 1 was generously supplied by Dr. 
John E. Pike o f  the Upjohn Co. and Prostaglandin A l 
was a gift o f  the One Company,  Tokyo ,  Japan.  PGB! 
was prcpaced from PGE t by heating in 0.5 N KOH 
in methano l -water  (1 : I ) at 55 -58  ° for 30 rain. The 
reaction mixture was then evaporated to dryness, dis- 
solved in water, acidified to pH = 3.O with I N HCI 
and extracted 3 times with 5 m! diethyl ether.  The 
pooled ether extracts were washed with water to 
pH = 6 .0 -6 .5 ,  d, ied over Na2SO 4 and evaporated to 
dryness. A recent report by Zusman [6] has indi- 
cated that tile method o fconver lmg PGE 1 to FGB i by 
heating in 1 N methanol':c KOH for 2 -5  rain at l O0 ° ntay 
yield products other than PGB I . I1~.e pur i ty o f  the 
prepared PGB t was therefore checked spec~rophoto- 
metrically. The product  was found to possess the 
characteristic absorpt ion spectrum of  PGB I wi~h an 
absorption tnaximuln at 278 nm.  
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r _ -~ ,-~-. I- l~tibit[on of  [3HIPGA~-anti-PGA~ btndivg by PGA t 
and PG, B~. Assay condit ions are described in Methods.  The 
an',isernm dilation employed was 1:800 (final dilution in the 
assay medium was 1:40130). 
PGA l antiserum was obtained from rabbits immu- 
nized with poly-Lqys ine-PGA l conjugate [5] .  The 
procedure mployed in the rad,~oimmunoassay h s
been described elsewhere [5].  
3. Results and discussion 
The PGA 1 antiseru~.n produced in rabbits immu- 
nized with a poly-L- lysine-PGA 1 conjugate bound 
50,~ of  the added [3H]PGA 1 (2000 cpm, 10 pg)at  a 
dilution o f  1:800 (final dilution of  the antiserum in 
the assay medium was I _'4000). The standard curve o f  
this ant,:serum with unlabeled PGA, and the cross 
reaction with unlabeled PGB t are shown in fig. 1. 
PGA l and PGB 1 appear to be equally effective in dis- 
placing antibody bound I3H]PGA. These results indi- 
cate that the antibod,.'e.~ we obtained possess very sim- 
ilar binding characleristit's towards PGA: and PGB 1. 
Support t'or this tentative conclusion wa, obtained 
from studies in which [3tlI'*GBI was first added to 
the PGA 1 antiserum. :rod then displaced by varying 
amounts of  unlabeled PGA 1 or PGB 1 . The results o f  
these experiments are given in fig. 2 and again indi- 
cate both PGA I and PGB 1 to be a.pprt;y':nmte.Iy equal 
in displacing the antibody-bound [311]PGBI. it 
should be emphasized that despite the apparent inabil- 
ity o f  the antibodies produced to distinguish between 
PGA 1 and PGBI,  they are nevertheless pecific for the 
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Fig. 2. lnlhibition o f  [ 3[-[]PGI$ I -ant i -pGAt binding by l~3A 
and PGB ! . Assay condit ions ate described in Methods. "I'he 
antiserum dilution employed was ! :400 (final dilution in the 
assay medium was 1:2000). 
cytopentene ring structure, showing only small cross 
react i~ty with PGE l , P~E2,  P~F2~ , and PG[ZIa [51 . 
Two conclusions can_ be drawn from these results. 
The first is that the affinity o f  tile antibodies for ini- 
tial binding o f  PGA ! is stronger than towards PG[I I 
since in order to achieve the same extent  of  binding 
(50%) of  [3H]prostaglandin, it was necessa;)" to use 
a more concentrated antiseium for PGB I (dilution of 
antiserum 1:400) than for I GA 1 (dilution o f  antiserum 
! :800). The second cc.nctusion is that the abilities of 
unlabeled FGA 1 and I~GB I to displace [311]prosta- 
glandin (PGA I o~ PGBI )  are very similar. Taken to- 
gether, these cor.clus,ons in6icate to us lhat the anti- 
bodies we obta i ,ed  were produced in response to the 
presence o f  PGA l-C°ntaining immunogen only and 
are directed against PGA 1 moieties, but are not capa- 
ble o f  distinguishing between the PGAj and I~B 1 
structures. Previous tudie:: [2, 3, 7] have indicated 
that the presence or absent e of  the hydroxy l  groups 
at C 9 and C ! 1 arid the keto group al C 9 are the m:-j0r 
factors in producing the specific immunogenic re- 
sponse against he par:icular prostaglandin molecule. 
The cyclopentene ring in both PGA l and PGB I is 
planar although structural differences between these 
two prostaglandins do exist (e.g. the orientations of 
the C 8 and CI2 side drains). These differences appear 
howe~er to be to~) small to affect significantly the 
overall binding nff'mities o f  anti-PGA t antibodies 
towards PGA 1 as compared to F-GB I . 
The for,~,mtion of  anti,bodies directed against PGA 1 
foliowiog ,mmunization with PGA l-containing 
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Fig. 3. Inh ib i t ion  o f  [31[ ]gGEt -ant i -PGEt  b ind ing by PGE 1 , 
PGA! and PGB t . Assay as descr ibed in MeOtods.  The antise- 
;am di lut ion employed  wns l: 1200.  
immunogen is in contradist inct ion to the results o f  
Jafl~ et al. [11, Levine et ai. 121 and Yu and Burke [31. 
levine and co-workers [2] have at tempted to prodttce 
antibodies to PGE I by immunizing rabbits with PGE l- 
p01y-L-iysine-succinylated h mocyanin.  The antibodies 
they obtained were however directed mainly against 
PGB t with weaker binding o f  PGA I and negligible 
binding o f  PGE 1 _ To account for these results, they 
proposed that PGE I was converted to PGA 1 dining 
the earbodiimide conjugation reaction, so that the 
conjugate used for immunizat ion contained FGA ! 
rather than PGE l_ They further propose that prosta- 
glandin isomerase activity: originally demonstrated by 
Jones in cat plasma [81 and more recently also in 
plasma o f  rabbif, dog and rat [9, IO[ catalyzes the m 
vh,o conversion o f  prote in-bound PGA I to PGB ! 
yielding an immunogen containing PGB t moieties. 
Support for this suggested mechanism was reported 
by Yu and Bttrke [3] who obtained PGE I antiserum 
which cross reacted to an equal or more extent  with 
PGA 1 and PGB t. They also obta ined PGA 1 antiserunl 
~itich cross reacted to a higher extent  with PGB t . 
The data presented here, while not  excluding the pos- 
sibility that such a mechanism is operative, indicates 
tha~ tt~e n~ethod of  imnlunizat ion as reported by 
Stytos and Rivetz [5l in which the poly-.l_-lysine- 
PGA I conjugate was absorbed to the Pneumococcus 
cells, prevented a possible conversion o f  FGA l to 
PGB 1 . In addit ion it was recently possible to obtain 
a PGE 1 antiserum with high specificity towards PGE~. 
Since both Levine et al. [2~ and Yu and Burke [3J 
have suggested that product ion o f  antibodies against 
E type prostaglandins without considerable cr~ss-reac- 
tivity with tile A and B prostaghmdins would be very 
difficult if  r,.ot impossible, we were interested in deter- 
mining the cross reactivities o f  the PGE t antiserum 
against PGA 1 and PGB 1 . l lmse results are given in 
fig. 3, and indicate that neither PGA 1 nor P(.;B 1 
could displace 50% of  tire [3H J PG E 1 initially bound. 
Accurate evaluation o f  the cross reactivittes o f  these 
pro,~a~andins were therefore not possible ; the cross 
reactivities are however less than !%. Of  special signif- 
i~.~ancc is the fact that the binding affinities o fPGA l 
and PGB I towards the PGE [ antibodies, how,±ver 
small, are nevertheless very similar. These results are 
in agreement with those obtained earlier (fig. 1 and 2) 
with regard to the relative binding aflinities o f  PGA ! 
and PGB I towards PGA I anti.~erum. 
A radioimmunoassay for prostaglandins provides a 
simple technique for the quantitalive detern;_i~]ation f  
these compounds in biological fluids and tissues. An 
absolute necessity for the development o f  a specific 
radioimmunoassay is the production o f  antibodies 
capable of  distinguishing between the various structur- 
ally related prostaglandins. Styles and Rivetz 15 J, by 
choosing a suitable protein conjugate in combinat ion 
with a ~cond carrier (Pneumococcus cell~)were able 
to prevent he possible conversion o f  PGA 1 ~o PGB I 
and thus olGtain a PGA I antiserum directed mainl3 
against PGA l . Furtttermore, the data pre~ented here 
on the cross reactivities of  the PGE ! anti~erum with 
PGA t and PGB t (fig. 3) indicates tha~ the chemical 
conversion of  PGE~ to PGA t at~d the ~.zymat ic  on- 
version of  PGA 1 to PGB 1 as suggested by Levine et al. 
[21 and Yn and Burke [3] ,  was blocked. It ttlercfere 
appears that the type of  protein carrier used for con- 
jugation and the method o f  immtmigation are the 
major determinants which affect the resulting speei- 
ficities o f  the antibodies produced, and that by prop- 
er selection o f  the.~ determinants, it is possible to ob- 
tain specific antibodies against prostaglandins E or 
prostaglandin A compounds.  
* The PGEt autis~rum was prepared at the Worcester 
F ,mudat ion.  Manuscript dealing with the method o f  prepara. 
tion and dciailed immunologic',d specificity is in prepztra- 
tion. 
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